Dae Won Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dae Won Kim has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Tiago Biachi De Castria
Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL
14 shared publications - Aleksandra Karolak
Department of Machine Learning, Moffitt Cancer Center
13 shared publications - Alexandra F. Tassielli
Department of Gastrointestinal Surgical Oncology and Gastroenterology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
13 shared publications - Andrew R. Judge
Department of Physical Therapy, College of Public Health and Health Professions, University of Florida
13 shared publications - Anjana A. Menon
Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
13 shared publications - Christopher J. Whelan
Department of Metabolism and Cancer Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA
13 shared publications
Latest Publications
- Open Access
Transcriptomic Profiling and Demographic Analysis of Appalachian Patients with Pancreatic Ductal Adenocarcinoma using the Purity Independent Subtyping of Tumors (PurIST) Classifier
PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy with poor prognosis. A transcriptomic-based algorithm called Purity Independent Subtyping of Tumors (PurIST) relies on expression profiling of a defined set of genes to stratify PDAC into classical and basal-like molecular subtypes and assigns a confidence level to the subtypes as either “strong,” “likely,” or “lean.” In this study, we apply PurIST to Appalachian and non-Appalachian patient cohorts and assess demographic variables between groups that may influence treatment outcomes. PATIENTS AND METHODS: This 13-site study includes 780 PDAC patients. Patients were divided into Appalachian and non-Appalachian cohorts according to Appalachian Regional Commission guidelines, and differences in PurIST classification, tobacco use, and alcohol use were analyzed. RESULTS: Individuals from Appalachian regions were more likely to receive a subtype classification from PurIST with “strong” confidence as opposed to “likely” or “lean” ( P =0.0175; odds ratio=1.66). We did not observe any significant difference between basal and classical subtype classification in Appalachia ( P =0.1457), yet an exploratory analysis showed that individuals aged ≥85 were significantly more likely to have basal-like tumor classifications ( P =0.005817; odds ratio=3.79). Appalachian patients were more likely to have a history of smoking (59.6% vs 49.9%; P =0.01756) and less likely to report alcohol consumption (50.5% vs 65.6%; P =0.000229). CONCLUSION: We conducted the largest comparison of the PurIST algorithm in Appalachia to date and found PurIST is more likely to have higher confidence in molecular subtype classifications for Appalachian PDAC tumors compared to non-Appalachian tumors. If PurIST is to be considered as a prognostic or decision-making tool for PDAC patients, we must account for variability in different populations and model the likelihood that tumors will have a strong molecular signature.
Open AccessTranscriptomic Profiling and Demographic Analysis of Appalachian Patients with Pancreatic Ductal Adenocarcinoma using the Purity Independent Subtyping of Tumors (PurIST) Classifier
PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is a deadly malignancy with poor prognosis. A transcriptomic-based algorithm called Purity Independent Subtyping of Tumors (PurIST) relies on expression profiling of a defined set of genes to stratify PDAC into classical and basal-like molecular subtypes and assigns a confidence level to the subtypes as either “strong,” “likely,” or “lean.” In this study, we apply PurIST to Appalachian and non-Appalachian patient cohorts and assess demographic variables between groups that may influence treatment outcomes. PATIENTS AND METHODS: This 13-site study includes 780 PDAC patients. Patients were divided into Appalachian and non-Appalachian cohorts according to Appalachian Regional Commission guidelines, and differences in PurIST classification, tobacco use, and alcohol use were analyzed. RESULTS: Individuals from Appalachian regions were more likely to receive a subtype classification from PurIST with “strong” confidence as opposed to “likely” or “lean” ( P =0.0175; odds ratio=1.66). We did not observe any significant difference between basal and classical subtype classification in Appalachia ( P =0.1457), yet an exploratory analysis showed that individuals aged ≥85 were significantly more likely to have basal-like tumor classifications ( P =0.005817; odds ratio=3.79). Appalachian patients were more likely to have a history of smoking (59.6% vs 49.9%; P =0.01756) and less likely to report alcohol consumption (50.5% vs 65.6%; P =0.000229). CONCLUSION: We conducted the largest comparison of the PurIST algorithm in Appalachia to date and found PurIST is more likely to have higher confidence in molecular subtype classifications for Appalachian PDAC tumors compared to non-Appalachian tumors. If PurIST is to be considered as a prognostic or decision-making tool for PDAC patients, we must account for variability in different populations and model the likelihood that tumors will have a strong molecular signature.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Mean total skeletal muscle area (tSMA) and psoas skeletal muscle area (pSMA) at diagnosis and follow-up among PDAC cohort participants overall and according to edema status.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Mean total skeletal muscle area (tSMA) and psoas skeletal muscle area (pSMA) at diagnosis and follow-up among PDAC cohort participants overall and according to edema status.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Changes in tSMA and pSMA by clinicodemographic covariates bar charts.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Changes in tSMA and pSMA by clinicodemographic covariates bar charts.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Select clinical and epidemiological characteristics of the study population of all PDAC patients in the FPC Cohort and according to those included versus excluded in the current analysis.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Select clinical and epidemiological characteristics of the study population of all PDAC patients in the FPC Cohort and according to those included versus excluded in the current analysis.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Adjusted mean change in total skeletal muscle area (tSMA) and psoas skeletal muscle area (pSMA) at L3 with pairwise comparisons by edema status.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Adjusted mean change in total skeletal muscle area (tSMA) and psoas skeletal muscle area (pSMA) at L3 with pairwise comparisons by edema status.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Directed acyclic graph for Cox proportional hazards regression. Directed acyclic graph representing all variables considered in building multivariable models for the Cox proportional hazards regression representing the associations of muscle changes with PDAC outcomes.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Directed acyclic graph for Cox proportional hazards regression. Directed acyclic graph representing all variables considered in building multivariable models for the Cox proportional hazards regression representing the associations of muscle changes with PDAC outcomes.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Inclusion and exclusion criteria flow chart.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Inclusion and exclusion criteria flow chart.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Forest plots of tSMA and pSMA changes and mortality.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Forest plots of tSMA and pSMA changes and mortality.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Adjusted mean change in total skeletal muscle area (tSMA) and psoas skeletal muscle area (pSMA) by clinically relevant covariables in subgroups by edema status.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Adjusted mean change in total skeletal muscle area (tSMA) and psoas skeletal muscle area (pSMA) by clinically relevant covariables in subgroups by edema status.
- Open Access
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Sensitivity analysis changes in tSMA and pSMA bar charts.
- 2 September 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma
Sensitivity analysis changes in tSMA and pSMA bar charts.